Francesca Punzo Selected Research

Francesca Punzo Research Topics

Disease

7	Neoplasms (Cancer) 08/2022 - 08/2017
7	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2017
5	Inflammation (Inflammations) 08/2022 - 09/2018
4	Thrombocytopenia (Thrombopenia) 01/2021 - 01/2011
4	Osteoporosis 07/2020 - 01/2017
3	Bone Resorption 11/2020 - 01/2017
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 11/2019 - 12/2011
3	Obesity 11/2019 - 09/2018
2	Celiac Disease (Celiac Sprue) 11/2020 - 11/2019
2	Immune System Diseases (Immune Disorders) 01/2020 - 11/2019
2	Iron Overload 04/2019 - 01/2018
2	Polycythemia (Erythrocytosis) 10/2013 - 01/2006
1	COVID-19 05/2020
1	Infections 05/2020
1	Neoplasm Metastasis (Metastasis) 02/2020
1	Hodgkin Disease (Hodgkin's Disease) 01/2020
1	Drug-Related Side Effects and Adverse Reactions 01/2020
1	Neuroinflammatory Diseases 11/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 11/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2019
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2019
1	Premature Birth (Birth, Premature) 10/2019
1	Insulin Resistance 12/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 11/2018
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 04/2018
1	Thalassemia 01/2018
1	Starvation 01/2017
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2017
1	Atrophy 01/2017
1	primary familial and congenital Polycythemia 10/2013
1	Hypoxia (Hypoxemia) 10/2013
1	Parkinsonian Disorders (Parkinsonism) 02/2011
1	Cognitive Dysfunction 02/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2011

Drug/Important Bio-Agent (IBA)

8	EndocannabinoidsIBA 08/2022 - 08/2017
7	Cannabinoid Receptors (Cannabinoid Receptor)IBA 08/2022 - 12/2011
4	CB2 Cannabinoid ReceptorIBA 08/2022 - 04/2018
3	IronIBA 01/2021 - 01/2017
2	CannabinoidsIBA 08/2022 - 09/2018
2	Deferasirox FDA Link 01/2021 - 01/2018
2	eltrombopag FDA Link 01/2021 - 01/2018
2	Chelating AgentsIBA 01/2021 - 01/2018
2	Thrombopoietin ReceptorsIBA 01/2021 - 01/2018
2	Estrogens (Estrogen)FDA Link 05/2020 - 04/2019
2	mifamurtideIBA 02/2020 - 01/2017
2	Biomarkers (Surrogate Marker)IBA 10/2019 - 12/2018
2	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 04/2018 - 08/2017
2	Erythropoietin FDA Link 10/2013 - 01/2006
1	EnzymesIBA 08/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Vitamin D FDA LinkGeneric 11/2020
1	iodopravadoline (AM 630)IBA 11/2020
1	LigandsIBA 07/2020
1	Monoclonal AntibodiesIBA 07/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2020
1	Denosumab FDA Link 07/2020
1	Brentuximab VedotinIBA 01/2020
1	GlucocorticoidsIBA 04/2019
1	Inosine Triphosphate (ITP)IBA 02/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2019
1	HLA-G Antigens (HLA G)IBA 12/2018
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2018
1	Bortezomib (Velcade)FDA Link 11/2018
1	UbiquitinIBA 11/2018
1	Calcium Channels (Calcium Channel)IBA 04/2018
1	Methylnitronitrosoguanidine (MNNG)IBA 08/2017
1	Codon (Codons)IBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	ElementsIBA 01/2017
1	Oxygen (Dioxygen)IBA 10/2013
1	Thrombopoietin (c-mpl Ligand)IBA 06/2011
1	Levodopa (L Dopa)FDA LinkGeneric 02/2011
1	5' Untranslated Regions (5' UTR)IBA 01/2011
1	Hemoglobins (Hemoglobin)IBA 01/2006

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 07/2020 - 01/2017
1	Adjuvant Chemotherapy 02/2020
1	Off-Label Use 01/2020
1	Therapeutics 11/2018
1	Drug Tapering 11/2018
1	Blood Transfusion (Blood Transfusions) 01/2018